SCHEMBL7522381

SCHEMBL7522381

C=CC[C@]1(C(=O)O)CCCN1C(=O)OCc1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7522377 1.00
SCHEMBL7522379 1.00
SCHEMBL6999083 0.89
SCHEMBL7207797 0.86
SCHEMBL7307500 0.86
SCHEMBL14673362 0.85
SCHEMBL6691770 0.85
SCHEMBL18760220 0.85
SCHEMBL2084143 0.84 PREP (0.47)
SCHEMBL7617089 0.83 MAPT (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020187934-A1 Peptide derivatives SYNGENTA LIMITED (GB) 2002-12-12 US disclosed
US-20020103335-A1 PEPTIDE DERIVATIVES ASTRAZENECA UK LIMITED (GB) 2002-08-01 US disclosed
US-6355617-B1 PEPTIDES, HYDROPHOBIC RESIDUES, AMINO ACIDS AND SEQUENCE SYNGENTA LIMITED (GB) 2002-03-12 US disclosed
EP-0882066-B1 PEPTIDE DERIVATIVES ZENECA LTD (GB) 2000-09-06 EP disclosed
US-6087336-A ANTIINFLAMMATORY AGENT TREATING RHEUMATOID ARTHRITIS ZENECA LIMITED (GB) 2000-07-11 US disclosed
EP-0946596-A1 PEPTIDE DERIVATIVES ZENECA LIMITED (GB) 1999-10-06 EP disclosed
EP-0914333-A1 PEPTIDE DERIVATIVES ZENECA LIMITED (GB) 1999-05-12 EP disclosed
EP-0882066-A1 PEPTIDE DERIVATIVES ZENECA LIMITED (GB) 1998-12-09 EP disclosed
WO-1998023644-A1 PEPTIDE DERIVATIVES ZENECA LIMITED (GB) 1998-06-04 WO disclosed
WO-1997046578-A1 PEPTIDE DERIVATIVES ZENECA LIMITED (GB) 1997-12-11 WO disclosed
WO-1997031023-A1 PEPTIDE DERIVATIVES ZENECA LIMITED (GB) 1997-08-28 WO disclosed